An open-label randomized comparative study of oral contraceptives between medications containing 3 mg drospirenone/30 μg ethinylestradiol and 150 μg …

W Suthipongse, S Taneepanichskul - Contraception, 2004 - Elsevier
This study was conducted to compare the cycle control, efficacy and adverse events of a
new low-dose oral contraceptive pill regimen containing 3 mg drospirenone (DRSP)/30 μg …

Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone

G Bachmann, PJ Sulak, C Sampson-Landers, N Benda… - Contraception, 2004 - Elsevier
The aim of this open-label, multicenter, noncomparative study was to determine the efficacy,
safety and bleeding profile of a new low-dose, monophasic combined oral contraceptive …

A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or …

JM Foidart, W Wuttke, GM Bouw… - … European Journal of …, 2000 - Taylor & Francis
Objective To assess the contraceptive reliability, cycle control and tolerance of a new
monophasic oral contraceptive (Yasmin®) containing 30 μg ethinylestradiol and 3 mg …

Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen

L Hernádi, J Marr, D Trummer, V De Leo, F Petraglia - Contraception, 2009 - Elsevier
OBJECTIVE: The study was conducted to assess the efficacy of a low-dose combined oral
contraceptive (COC) containing drospirenone (drsp) 3 mg/ethinylestradiol (EE) 20 mcg …

A historical cycle control comparison of two drospirenone-containing combined oral contraceptives: ethinylestradiol 30 μg/drospirenone 3 mg administered in a 21/7 …

J Marr, C Gerlinger, M Kunz - European Journal of Obstetrics & Gynecology …, 2012 - Elsevier
OBJECTIVES: To compare the bleeding patterns and cycle control of an oral contraceptive
(OC) containing ethinylestradiol (EE) 30μg/drospirenone (drsp) 3mg administered in a 21/7 …

Bleeding pattern with drospirenone 3 mg+ ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ ethinyl estradiol 20 mcg 21 …

L Anttila, M Kunz, J Marr - Contraception, 2009 - Elsevier
BACKGROUND: The study was conducted to compare cycle control, bleeding pattern and
efficacy of two low-dose combined oral contraceptives. STUDY DESIGN: Four hundred fifty …

Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone

J Huber, JM Foidart, W Wuttke… - … European Journal of …, 2000 - Taylor & Francis
Objective To assess the contraceptive reliability, cycle control and tolerability of a new
monophasic oral contraceptive containing 30 g ethinylestradiol plus 3 mg drospirenone …

Efficacy and safety of a low-dose 21-day combined oral contraceptive containing ethinylestradiol 20μg and drospirenone 3mg

D Cibula, U Karck, HG Weidenhammer, J Kunz… - Clinical drug …, 2006 - Springer
Objective: The purpose of this study was to assess the efficacy and safety of a new low-dose
oral contraceptive containing ethinylestradiol 20μg and drospirenone 3mg (EE 20μg/drsp …

Efficacy and safety of the combined oral contraceptive ethinylestradiol/drospirenone (Yasmin®) in healthy Chinese women: a randomized, open-label, controlled …

F Guang-Sheng, B Mei-Lu, C Li-Nan… - Clinical Drug …, 2010 - Springer
Objective: To evaluate and compare the contraceptive efficacy, bleeding pattern, side effects
and other positive effects of a combined oral contraceptive (COC) containing drospirenone …

[PDF][PDF] A study of cycle control, side effects and client's satisfaction of a low dose combined contraceptive containing ethinylestradiol/drospirenone (24/4 regimen)

N Chaiyasit, S Taneepanichskul - J. Med. Assoc. Thai, 2010 - thaiscience.info
Objective: To study cycle control, side effects, and satisfaction of low dose 24-day combined
contraceptive containing 20 μg of Ethinylestradiol and 3 mg of Drospirenone. Material and …